NCT00493948View on ClinicalTrials.gov

Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Heart Failure, CongestiveSleep Apnea Syndromes
Interventions
DEVICE

ApneaLink

A two channel sleep screening device for the assessment of Sleep Disordered Breathing.

Trial Locations (1)

2050

Royal Prince Alfred Hospital, Camperdown

Sponsors

Lead Sponsor

ResMed
All Listed Sponsors
lead

ResMed

INDUSTRY

NCT00493948 - Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure | Biotech Hunter | Biotech Hunter